Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

New Trends in the Immunopathogenesis of Psoriasis (CROSBI ID 117581)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Kaštelan, Marija ; Prpić Massari, Larisa ; Pašić, Aida ; Gruber, Franjo New Trends in the Immunopathogenesis of Psoriasis // Acta Dermatovenerologica Croatica, 12 (2004), 1; (26-29)-x

Podaci o odgovornosti

Kaštelan, Marija ; Prpić Massari, Larisa ; Pašić, Aida ; Gruber, Franjo

engleski

New Trends in the Immunopathogenesis of Psoriasis

Psoriasis is a chronic hyperproliferative inflammatory skin disease characterized by abnormal keratinocyte hyperproliferation and differentiation, intra-epidermal accumulation of neutrophil granulocytes, and dermal inflammatory infiltrate that mostly consists of T-cells. Today, psoriasis is definitely recognized as a T-cell-mediated inflammatory disease. Infiltration of T-cells seems to be the primary event that precedes the keratinocyte hyperproliferation. It is suggested that systemic lymphocity activation is followed by the activation of intradermal CD8+ T-cells. So far, it seems that CD4+ T-cells create an appropriate type-1 cytokine environment for CD8 T-cells activation that eventually trigger the psoriatic cascade. Thus, T-cells are responsible for initiation and maintenance of psoriasis.However, it seems that the specific immune reaction to a putative antigen, mediated by T-cells leads to creation of psoriatic lesions. The immune reaction constantly driven by bacterial superantigens or epidermal self-antigens eventually leads to development of psoriatic lesions. The psoriatic process is a dynamic process that includes interaction between Th1- and Tc1-cells as well as between T-cells and keratinocytes. The better understanding of the immunopathogenesis of psoriasis would allow for development of specific T-cell-targeted and/or cytokine-targeted new therapies.

(cytokines; immunopathogenesis; keratinocytes; T lymphocytes)

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

12 (1)

2004.

(26-29)-x

objavljeno

1330-027X

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost